Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Pain and Sleep Quality of Infants With Congenital Pulmonary Cystic Disease After Thoracoscopic Surgery

April 21, 2026 updated by: Lei Xiaoming
This study intends to evaluate the effect of erector spinae plane block on postoperative analgesia and sleep quality in infants with congenital cystic pulmonary disease after thoracoscopic surgery, and provides reference for perioperative pain treatment in children.

Study Overview

Detailed Description

Severe pain may occur after pediatric thoracic surgery, such as skin incision, rib traction, drainage tube placement, or intercostal nerve dysfunction caused by suture. Pain may cause weakened coughing power to clear secretions, decreased functional residual capacity, leading to pulmonary complications such as atelectasis and pneumonia, and postoperative acute pain develops into chronic pain. It has been reported that postoperative sleep disorders are associated with increased pain scores, which are very unfavorable for postoperative rehabilitation of pediatric patients. In clinical practice, because infants cannot accurately describe pain, their postoperative pain management may not be sufficient and has not received enough attention. But, some studies have shown that infants may feel more severe pain than adults, and the pain has a more obvious and lasting effect on infants and young children than on adults.

Congenital pulmonary cystic disease is a rare congenital pulmonary developmental abnormality in clinic. It can't heal itself and is easy to cause various complications. Once diagnosed, surgical treatment should be considered immediately.

In the past experience, thoracic epidural block and thoracic paravertebral nerve block are commonly used for postoperative analgesia in thoracic surgery, but they have taboos such as abnormal coagulation function, high technical requirements and potential risks of serious complications.

Since the erector spinae plane block (ESPB) was first reported and successfully implemented in 2016, because it is far away from the neural axis, major vascular structures, pleura and other structures, with a lower possibility of complications, simpler operation and higher safety, it has been widely used in perioperative analgesia and acute and chronic pain in cardiothoracic surgery, breast surgery, abdominal surgery, spinal surgery, etc. However, the reports on pediatric patients are still mainly case reports, and there is a lack of large-sample randomized controlled clinical trials. Therefore, this study intends to perform erector spinae plane block under ultrasound guidance to observe the effect on postoperative analgesia and sleep quality in pediatric thoracoscopic surgery.

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanxi
      • Xi’an, Shanxi, China, 710004
        • Second Affiliated Hospital of Xi 'an Jiaotong University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • American Society of Anesthesiologists (ASA) status I-II
  • age 1 month - 12 mouths old
  • preoperative diagnosis was congenital cystic lung disease
  • thoracoscopic lung lesion resection(lung lobectomy or segmentectomy)

Exclusion Criteria:

  • patient with a history of allergy to amide local anesthetics
  • family members refused to participate in the study.
  • combined congenital heart disease
  • patient with skin damage or infection at the proposed puncture site
  • patients with scoliosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: E group
0.25 % ropivacaine ( 0.5ml / kg )
After the operation, unilateral erector spinae plane block was performed at the T5 level under ultrasound guidance.
Experimental: P group
0.25 % ropivacaine ( 0.5ml / kg )
After the operation, Incision infiltration of local anesthesia is performed around the surgical incisions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
postoperative FLACC score
Time Frame: 2, 4, 6, 12, 24, 48 hours after operation
2, 4, 6, 12, 24, 48 hours after operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative sleep quality score
Time Frame: 1, 2, 3, 4, 5, 6, 7 days after operation
The Pittsburgh Sleep Quality Index was used to evaluate the sleep quality of children 7 days after surgery.
1, 2, 3, 4, 5, 6, 7 days after operation
Number of participants with emergence agitation as assessed by PAED
Time Frame: from extubation to the child is sent back to the ward, an average of 40 minutes
The Pediatric Anesthesia Emergence Delirium (PAED) was used to evaluate emergence agitation after extubation in post-anesthesia care unit.
from extubation to the child is sent back to the ward, an average of 40 minutes
the amount of postoperative rescue analgesia ( with a FLACC score of >4)
Time Frame: 2, 4, 6, 12, 24, 48 hours after operation
ibuprofen (5-10mg/kg) was intravenously administered as rescue analgesia.
2, 4, 6, 12, 24, 48 hours after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Xiaoming Lei, chief physician, Second Affiliated Hospital of Xi 'an Jiaotong University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 9, 2024

Primary Completion (Actual)

February 28, 2025

Study Completion (Actual)

March 3, 2025

Study Registration Dates

First Submitted

June 28, 2024

First Submitted That Met QC Criteria

July 6, 2024

First Posted (Actual)

July 12, 2024

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cystic Adenomatoid Malformation of Lung, Congenital

Clinical Trials on Ropivacaine

Subscribe